Literature DB >> 16162151

Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease.

Gabriel Perlemuter1, Anne Davit-Spraul, Claudine Cosson, Marc Conti, Amélie Bigorgne, Valérie Paradis, Marie-Pierre Corre, Lydie Prat, Viceth Kuoch, Arnaud Basdevant, Gilles Pelletier, Jean-Michel Oppert, Catherine Buffet.   

Abstract

AIMS: Steatosis may increase oxidative stress, which is counteracted by cellular enzymatic (cytosolic and mitochondrial superoxide dismutases (Cu/Zn-SOD and Mn-SOD), glutathione peroxidase (GPx), catalase) and non-enzymatic antioxidant systems. We aimed to determine, in patients with non-alcoholic fatty liver disease (NAFLD), the level of antioxidant defenses (1) in liver biopsies, to demonstrate the existence of oxidative stress; (2) in erythrocytes and plasma, to determine whether their antioxidant defenses reflect liver oxidative stress.
METHODS: Erythrocyte and plasma antioxidant defenses were prospectively studied in two groups of 16 patients: patients with NAFLD and controls. Liver biopsies were performed in eight NAFLD patients; liver antioxidant enzyme activities were measured and compared with those in 12 control livers used for transplantation.
RESULTS: Cu/Zn-SOD, GPx and catalase activities were significantly higher in NAFLD livers than in controls whereas no significant differences were observed in Mn-SOD activity, and thiobarbituric acid-reactive substance (TBARS) concentration. No differences were observed in erythrocyte antioxidant enzyme activities (GPx, catalase, Cu/Zn-SOD), erythrocyte TBARS concentration, and plasma alpha-tocopherol concentration.
CONCLUSIONS: Liver antioxidant enzyme activities were high in patients with NAFLD, reflecting an oxidative stress possibly involved in inflammation and fibrogenesis. However, erythrocyte and plasma antioxidant defenses did not reflect intrahepatic peroxidation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162151     DOI: 10.1111/j.1478-3231.2005.01126.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  24 in total

Review 1.  Carotenoids and non-alcoholic fatty liver disease.

Authors:  Bahiddin Yilmaz; Kazim Sahin; Hande Bilen; Ibrahim H Bahcecioglu; Birdal Bilir; Sara Ashraf; Karim J Halazun; Omer Kucuk
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

Review 2.  Effects of red wine on postprandial stress: potential implication in non-alcoholic fatty liver disease development.

Authors:  Ilaria Peluso; Husseen Manafikhi; Raffaella Reggi; Maura Palmery
Journal:  Eur J Nutr       Date:  2015-03-16       Impact factor: 5.614

3.  A maternal "junk food" diet in pregnancy and lactation promotes nonalcoholic Fatty liver disease in rat offspring.

Authors:  Stéphanie A Bayol; Bigboy H Simbi; Robert C Fowkes; Neil C Stickland
Journal:  Endocrinology       Date:  2010-03-05       Impact factor: 4.736

4.  A 7-day profile of oxidative stress and antioxidant status in patients with acute liver failure.

Authors:  Vikram Bhatia; Payal Bhardwaj; Jessina Elikkottil; Jyoti Batra; Anoop Saraya
Journal:  Hepatol Int       Date:  2008-09-16       Impact factor: 6.047

5.  Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease.

Authors:  Payal Bhardwaj; Kaushal Madan; Sandeep Thareja; Yogendra Kumar Joshi; Anoop Saraya
Journal:  Hepatol Int       Date:  2008-02-27       Impact factor: 6.047

6.  Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease.

Authors:  Anatol Panasiuk; Janusz Dzieciol; Bozena Panasiuk; Danuta Prokopowicz
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

Review 7.  Catalase and nonalcoholic fatty liver disease.

Authors:  Su-Kyung Shin; Hyun-Woo Cho; Seung-Eun Song; Dae-Kyu Song
Journal:  Pflugers Arch       Date:  2018-08-17       Impact factor: 3.657

8.  Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis.

Authors:  Hana Malínská; Olena Oliyarnyk; Miriam Hubová; Václav Zídek; Vladimír Landa; Miroslava Simáková; Petr Mlejnek; Ludmila Kazdová; Theodore W Kurtz; Michal Pravenec
Journal:  Mol Cell Biochem       Date:  2009-09-12       Impact factor: 3.396

Review 9.  Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease.

Authors:  Peter R Baker; Jacob E Friedman
Journal:  J Clin Invest       Date:  2018-08-31       Impact factor: 14.808

10.  Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis.

Authors:  Claudia von Montfort; Núria Matias; Anna Fernandez; Raquel Fucho; Laura Conde de la Rosa; Maria Luz Martinez-Chantar; José M Mato; Keigo Machida; Hidekazu Tsukamoto; Michael P Murphy; Abdellah Mansouri; Neil Kaplowitz; Carmen Garcia-Ruiz; Jose C Fernandez-Checa
Journal:  J Hepatol       Date:  2012-06-09       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.